A carregar...
MEK1 is associated with carboplatin resistance and is a prognostic biomarker in epithelial ovarian cancer
BACKGROUND: Primary systemic treatment for ovarian cancer is surgery, followed by platinum based chemotherapy. Platinum resistant cancers progress/recur in approximately 25% of cases within six months. We aimed to identify clinically useful biomarkers of platinum resistance. METHODS: A database of o...
Na minha lista:
| Publicado no: | BMC Cancer |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4247127/ https://ncbi.nlm.nih.gov/pubmed/25408231 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-837 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|